Our research commenced with an examination of TIMM17A expression levels in LUAD, utilizing data from the Cancer Genome Atlas (TCGA), Clinical Proteomic Tumor Analysis Consortium (CPTAC), and Human Protein Atlas (HPA) to analyze both mRNA and protein expression profiles. Here, TIMM17A is linked to neoplasm.